Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2017 16:05 ET | Source: Organovo, Inc.

Organovo Announces Fiscal Second-Quarter 2018 Results; Company Shifts Commercial Focus to Higher-Value Disease Modeling Opportunities and Updates Full-Year Fiscal 2018 Outlook

SAN DIEGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today reported financial results for the fiscal second quarter of 2018 and updated its full-year...
November 06, 2017 08:05 ET | Source: Organovo, Inc.

Organovo and Viscient Biosciences Collaborate to Develop Custom Research Platform for Studying Liver Disease

SAN DIEGO, Nov. 06, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) and Viscient Biosciences (“Viscient”) today announced a collaboration to develop a custom research...
October 20, 2017 08:05 ET | Source: Organovo, Inc.

Organovo Presents New Preclinical Data on 3D Bioprinted Human Liver Tissues for the Treatment of Inborn Errors of Metabolism at The Liver Meeting® 2017 (AASLD)

SAN DIEGO, Oct. 20, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today presented new preclinical data showing extended survival and sustained functionality of its 3D...
October 19, 2017 08:05 ET | Source: Organovo, Inc.

Organovo Announces Release Date for Fiscal Second-Quarter 2018 Financial Results

SAN DIEGO, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, November 9, 2017 at 5:00 p.m. Eastern Time (ET) to discuss...
October 04, 2017 17:05 ET | Source: Organovo, Inc.

Organovo Announces Preliminary Fiscal Second-Quarter Total Revenue; Company Restructures to Improve Operational Efficiency

SAN DIEGO, Oct. 04, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today reported preliminary unaudited total revenue for the fiscal second quarter of 2018. The Company...
August 23, 2017 08:05 ET | Source: Organovo, Inc.

Organovo Sponsors Pioneering Research With Amgen and Medikine in Critical Areas of Liver and Kidney Disease

SAN DIEGO, Aug. 23, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced it has awarded the 2017 ExVive 3D Tissue Application Award to researchers at Amgen,...
August 09, 2017 16:05 ET | Source: Organovo, Inc.

Organovo Announces Fiscal First-Quarter 2018 Results; Company Affirms Full-Year Fiscal 2018 Outlook

SAN DIEGO, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today reported financial results for the fiscal first quarter of 2018 and affirmed its full-year...
July 31, 2017 08:05 ET | Source: Organovo, Inc.

Organovo and UC San Diego Receive $1.7 Million Grant From National Institutes of Health to Study Liver Disease

SAN DIEGO, July 31, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced it has received a three-year, $1.7 million grant from the National Institutes of...
July 18, 2017 08:05 ET | Source: Organovo, Inc.

Organovo Announces Release Date for Fiscal First-Quarter 2018 Financial Results

SAN DIEGO, July 18, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Wednesday, August 9, 2017 at 5:00 p.m. Eastern Time (ET) to discuss the...
June 07, 2017 16:05 ET | Source: Organovo, Inc.

Organovo Announces Fiscal Fourth-Quarter and Full-Year 2017 Results; Company Issues Full-Year Fiscal 2018 Outlook

SAN DIEGO, June 07, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today reported financial results for the fiscal fourth quarter of 2017 and issued its full-year fiscal...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right